Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (41)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by SCHMIDT, B.
Right arrow Articles by HARTUNG, H.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SCHMIDT, B.
Right arrow Articles by HARTUNG, H.-P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 115, No. 6, 1633-1646, 1992
© 1992 Guarantors of Brain


research-article

TRANSIENT CELLULAR EXPRESSION OF {Gamma}-INTERFERON IN MYELIN-INDUCED AND T-CELL LINE-MEDIATED EXPERIMENTAL AUTOIMMUNE NEURITIS

BEATE SCHMIDT1,2, GUIDO STOLL1, PETER VAN DER MEIDE3, STEFAN JUNG2 and HANS-PETER HARTUNG2

1Department of Neurology, Heinrich-Heine-Universitât, Düsseldorf Würzburg, Germany 2Department of Neurology Julius-Maximilians-Universitât Würzburg, Germany 3TNO Institute of Applied Radiobiology and Immunology Rijswijk, The Netherlands

Correspondence to: Correspondence to: Guido Stoll, MD, Department of Neurology, Heinrich-Heine-Universität, Moorenstr. 5, D-4000 Düsseldorf, Germany.

This study reports the cellular localization of {Gamma}-interferon ({Gamma}-IFN) in nerve roots during the course of experimental autoimmune neuritis induced either by active immunization (EAN) or adoptive transfer of P2-specific T-cells (AT-EAN). One micrometre thick cryosections of ventral roots of EAN and AT-EAN animals were labelled with the monoclonal antibodies DB-1 and DB-12 recognizing different epitopes of rat {Gamma}-IFN. In EAN numerous {Gamma}-IFN-positive cells were present before overt clinical signs and demyelination (days 11 - 13 after immunization). Concomitantly, raised {Gamma}-IFN levels were measured in the serum of these animals. However, systemically increased {Gamma}-IFN serum levels were not specific for a neuritogenic T-cell response. At subsequent stages when many axons were demyelinated (day 16 and later) {Gamma}-IFN-positive cells had disappeared and {Gamma}-IFN serum levels returned to normal value. {Gamma}-Interferon positive cells could be identified as W3/13 positive T-cells and polymorphonuclear leukocytes. Additionally, a considerable number of EDI-positive macrophages showed {Gamma}-IFN immunoreactivity. The majority of macrophages and all Schwann cells were {Gamma}-IFN negative. Similar results were obtained in AT-EAN 4 d and 6 d following cell transfer. After nerve transection no {Gamma}-IFN-positive cells were found in the distal stumps. The localization of {Gamma}-IFN in nerve roots indicates an important role of this lymphokine in acute immune-mediated demyelination. {Gamma}-Interferon most likely locally affects macrophage functions such as migration, major histocompatibility complex (MHC) class II antigen (Ia) expression, and production of cytotoxic molecules in nerves, and thereby contributes to myelin damage.

Received August 29, 1991. Revised June 8, 1992. Accepted June 14, 1992.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Arch NeurolHome page
W. Hu, T. Dehmel, J. Pirhonen, H.-P. Hartung, and B. C. Kieseier
Interleukin 23 in acute inflammatory demyelination of the peripheral nerve.
Arch Neurol, June 1, 2006; 63(6): 858 - 864.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
R Kiefer, F Dangond, M Mueller, K V Toyka, D A Hafler, and H-P Hartung
Enhanced B7 costimulatory molecule expression in inflammatory human sural nerve biopsies
J. Neurol. Neurosurg. Psychiatry, September 1, 2000; 69(3): 362 - 368.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.